On the afternoon of June 23rd, the 14th Pharmaceutical Industry Internationalization Development Conference, jointly organized by China Chamber of Commerce for Import and Export of Pharmaceuticals and Health Products and Informa Markets, was successfully held in Shanghai. At the meeting, the group standard of “Guide for Sustainable Development of International Supply Chain in Pharmaceutical Industry” was released, and Huihong Pharmaceutical Company under Jiangsu Province Soho Holding Group became the first batch of enterprises complying with the standard through the audit and certification of the third-party organization, Shenzhen Tianxiang Quality and Technical Services Co.
June 25, China Chamber of Commerce for Import and Export of Pharmaceuticals and Health Products Wang Maochun, vice president of the 23rd World Pharmaceuticals and Pharmaceutical Ingredients Exhibition (CPHI China 2025), for Huihong Pharmaceuticals issued a certificate of compliance with the “Pharmaceutical Industry International Supply Chain Sustainability Guidelines” standard, reflecting the company’s management structure, quality system security, labor and social responsibility. Management structure, quality system security, labor norms and other dimensions to achieve the standardization, systematization, digital operation and management goals.
As the first group standard focusing on the sustainable development of international supply chain in the pharmaceutical industry, the Guide to Sustainable Development of International Supply Chain of Pharmaceutical Industry has built a four-dimensional framework covering “governance system, social responsibility, environmental protection, quality and safety”, and realized three breakthrough innovations: firstly, in-depth compatibility with the international rules, and secondly, seamless connection with more than 30 international standards such as the European Union’s Sustainable Product Eco-design Regulation. Second, it seamlessly connects with the European Union’s Sustainable Product Eco-design Regulation, and third, it closely connects with more than 30 international standards such as the World Health Organization and the International Coordination Committee for the Registration of Pharmaceuticals for Human Use. The Development Guide assessed more than 10 pharmaceutical enterprises, and announced the list of assessed enterprises to overseas buyers during the exhibition to set up a Chinese model of green pharmaceutical supply chain, which will tailor the sustainable development path for the internationalization of China’s pharmaceutical industry and promote the integration of China’s wisdom into the global health governance system.
Huihong Pharmaceutical Company will take this opportunity to further promote the enterprise’s comprehensive governance capacity, resource integration capacity, business innovation capacity upgrading and upgrading, and continue to focus on the construction of the main medical field of the main business, and continue to enhance their core competitiveness.